Role of PCGEM1 in Breast Cancer

Starting soon

Conditions studied: Breast Cancer

In brief

This study examines certain molecular markers in breast cancer using blood and tissue samples from routine diagnostic biopsies. No extra procedures will be performed on patients. The goal is to improve understanding of disease mechanisms and identify potential targets for treatment

Key facts

Study ID

NCT07562789

Run by

Assiut University

People needed

90

Starts

2026-05-05

Expected to finish

2026-08-06

Last updated by the study team

2026-05-01

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Age: 18 years and older.
• Newly diagnosed patients with histopathological confirmation of the diagnosis of breast cancer at any stage.

You may not qualify if…

• Presence of any chronic diseases.
• Previous history of breast cancer or other malignancies.
• Evidence of distant metastasis at the time of diagnosis.
• Prior treatment with chemotherapy or radiotherapy.
• Incomplete clinical or laboratory data.

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.